This distinguished group of proven professionals has collectively brought to market more than 200 pharmaceutical products, including some of the largest blockbusters in the world. The team possesses a remarkable depth and range of strategic and practical expertise that is unmatched by any other consulting service available today. Patheon¹s Certified Consultants include:
-Leah Appel 20 years development experience at Bend Research and INTERx. Co-inventor of over 35 drug delivery patents and applications.
-Brett Berner 30 years product development experience at Depomed, Cygnus and Ciba. Ten marketed products and 30 drug delivery patents.
-Lynn Van Campen 30 years development experience at Pfizer, Boehringer Ingelheim, Inhale/Nektar and the University of Wisconsin. Contributed to 18 marketed products.
-Joe Fix 30 years development experience at CyDex, NanoSystems/Elan, Yamanouchi and Alza. Contributed to 24 patents including four NECs, 13 LCMs, four OTCs and three generics.
-Larry Gatlin 25 years experience, including Genentech, Glaxo and Pfizer. Multiple patents, INDs and NDAs, over 20 publications.
-John Kent 30 years development experience at Theravance, Syntex and Allergan. More than 20 products and CMC, IND and NDA filings.
-Bob Lipper 30 years product development experience at Pfizer and BMS. Ushered multiple products through the R&D process.
-Doug Mendenhall 35 years experience at Abbott, Glaxo/GSK and Merck. Contributed to 70 commercial products.
-George Mooney 30 years development experience at Boehringer Ingelheim, Lederle and Pfizer. 100 NME, INDs, 15 NCEs, NDAs and over 30 products.
-Ann Newman 20 years experience at BMS and SSCI/Aptuit. Contributed to eight commercial products.
-Rodney Pearlman 30 years development experience at Eli Lilly, Genentech and Valentis. CEO of two start-ups Saegis and Nuon.
-Mark Staples 27 years experience with early and mid-stage companies. Contributed to the launch of three products both biologic and small molecule.
All professionals are equipped to serve as a critical advisor or hands-on partner to organizations of any size as they make their critical decisions to transition molecules from discovery to development and scale-up. Patheon has created this program to make sure that the industry has access to world-class independent advice.
Companies in this press-release
